Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

    Published: November 29, 2023 | Price: $5,000.00 – $10,000.00

    In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare.  For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost.  While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...
    World Market for Cardiac Markers (POC and Lab-Based)

    Published: January 7, 2022 | Price: $3,750.00 – $7,500.00

    It’s estimated that cardiovascular diseases, including those of the blood vessels supplying the heart muscle and the brain, are the leading cause of death globally. With the incidence of cardiovascular disease going through the roof, Kalorama Information’s report, World Market for Cardiac Markers (POC and Lab-Based), covers why cardiac markers are in huge demand and a constant subject of research for improvement. Cardiac biomarkers are substances that are released into the bloodstream when the heart is damaged or stressed. In...
    The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others)

    Published: March 23, 2021 | Price: $5,000.00 – $10,000.00

    Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. This report focuses on diagnostics.  The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2015 to 2024,...
    Sepsis Diagnostics Products and Market Trends

    Published: October 26, 2020 | Price: $3,000.00 – $6,000.00

    The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.   This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...